![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Samuel N Frempong, Andrew J Sutton, Clare Davenport & Pelham Barton. (2018) Economic evaluation of medical tests at the early phases of development: a systematic review of empirical studies. Expert Review of Pharmacoeconomics & Outcomes Research 18:1, pages 13-23.
Read now
Read now
Articles from other publishers (39)
Stephanie A. Robinson, Marilyn L. MoyJohn P. Ney. (2023) Value of Information Analysis of a Web-Based Self-Management Intervention for Chronic Obstructive Pulmonary Disease. Telemedicine and e-Health.
Crossref
Crossref
Rachael Y. Jablonski, Trevor J. Coward, Paul Bartlett, Andrew J. Keeling, Chris Bojke, Sue H. Pavitt & Brian R. Nattress. (2023) IMproving facial PRosthesis construction with contactlESs Scanning and Digital workflow (IMPRESSeD): study protocol for a feasibility crossover randomised controlled trial of digital versus conventional manufacture of facial prostheses in patients with orbital or nasal facial defects. Pilot and Feasibility Studies 9:1.
Crossref
Crossref
Alfred P. Yoon, David W. Hutton & Kevin C. Chung. (2023) Cost-effectiveness of surgical treatment of thumb carpometacarpal joint arthritis: a value of information study. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Crossref
Clarabelle T. Pham, Renuka Visvanathan, Mark Strong, Edward C. F. Wilson, Kylie Lange, Joanne Dollard, Damith Ranasinghe, Keith Hill, Anne Wilson & Jonathan Karnon. (2022) Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals. Applied Health Economics and Health Policy 21:2, pages 315-325.
Crossref
Crossref
Tingting Qiu, Michal Pochopien, Shuyao Liang, Gauri Saal, Ewelina Paterak, Justyna Janik & Mondher Toumi. (2022) Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment. Frontiers in Public Health 10.
Crossref
Crossref
Fernanda S. Tonin, Leticia P. Leonart & Cesar Casas. 2020. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy
1
19
.
Kim Edmunds, Paul Scuffham, Penny Reeves, Daniel A. Galvão, Dennis R. Taaffe, Robert U. Newton, Nigel Spry, David Joseph & Haitham Tuffaha. (2021) Demonstrating the value of early economic evaluation alongside clinical trials: Exercise medicine for men with metastatic prostate cancer. European Journal of Cancer Care 30:5.
Crossref
Crossref
Haitham Tuffaha, Claire Rothery, Natalia Kunst, Chris Jackson, Mark Strong & Stephen Birch. (2021) A Review of Web-Based Tools for Value-of-Information Analysis. Applied Health Economics and Health Policy 19:5, pages 645-651.
Crossref
Crossref
Peter Ghijben, Dennis Petrie, Silva Zavarsek, Gang Chen & Emily Lancsar. (2021) Healthcare Funding Decisions and Real-World Benefits: Reducing Bias by Matching Untreated Patients. PharmacoEconomics 39:7, pages 741-756.
Crossref
Crossref
Haitham Tuffaha. (2020) Value of Information Analysis: Are We There Yet?. PharmacoEconomics - Open 5:2, pages 139-141.
Crossref
Crossref
Guang Zou, Michael Havbro Faber, Arturo González & Kian Banisoleiman. (2021) Computing the value of information from periodic testing in holistic decision making under uncertainty. Reliability Engineering & System Safety 206, pages 107242.
Crossref
Crossref
Daniel Hill‐McManus & Dyfrig A. Hughes. (2020) Combining Model‐Based Clinical Trial Simulation, Pharmacoeconomics, and Value of Information to Optimize Trial Design. CPT: Pharmacometrics & Systems Pharmacology 10:1, pages 75-83.
Crossref
Crossref
Stephen C. Newbold & Robert J. Johnston. (2020) Valuing non-market valuation studies using meta-analysis: A demonstration using estimates of willingness-to-pay for water quality improvements. Journal of Environmental Economics and Management 104, pages 102379.
Crossref
Crossref
Gian Luca Di Tanna, Shuxian Chen, Anna Bychenkova, Heidi S. Wirtz, Karen L. Burrows & Gary Globe. (2019) Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers. PharmacoEconomics - Open 4:3, pages 397-401.
Crossref
Crossref
Claudia Fischer, Eva Chwala & Judit Simon. (2020) Methodological aspects of economic evaluations conducted in the palliative or end of life care settings: a systematic review protocol. BMJ Open 10:5, pages e035760.
Crossref
Crossref
Haitham W. Tuffaha, Joanne Aitken, Suzanne Chambers & Paul A. Scuffham. (2019) A Framework to Prioritise Health Research Proposals for Funding: Integrating Value for Money. Applied Health Economics and Health Policy 17:6, pages 761-770.
Crossref
Crossref
Kevin Jenniskens, Ghizelda R. Lagerweij, Christiana A. Naaktgeboren, Lotty Hooft, Karel G.M. Moons, Judith M. Poldervaart, Hendrik Koffijberg & Johannes B. Reitsma. (2019) Decision analytic modeling was useful to assess the impact of a prediction model on health outcomes before a randomized trial. Journal of Clinical Epidemiology 115, pages 106-115.
Crossref
Crossref
Barnaby D. Dunn, Heather O'Mahen, Kim Wright & Gary Brown. (2019) A commentary on research rigour in clinical psychological science: How to avoid throwing out the innovation baby with the research credibility bath water in the depression field. Behaviour Research and Therapy 120, pages 103417.
Crossref
Crossref
Eric Jutkowitz, Fernando Alarid-Escudero, Karen M. Kuntz & Hawre Jalal. (2019) The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis. PharmacoEconomics 37:7, pages 871-877.
Crossref
Crossref
Gert J. van der Wilt, Janneke P. C. Grutters, Angela H. E. M. Maas & Herbert J. A. Rolden. (2018) Combining value of information analysis and ethical argumentation in decisions on participation of vulnerable patients in clinical research. BMC Medical Ethics 19:1.
Crossref
Crossref
Hendrik KoffijbergClaire RotheryKalipso ChalkidouJanneke Grutters. (2018) Value of Information Choices that Influence Estimates: A Systematic Review of Prevailing Considerations. Medical Decision Making 38:7, pages 888-900.
Crossref
Crossref
Lauren E. Cipriano, Jeremy D. Goldhaber-FiebertShan LiuThomas A. Weber. (2018) Optimal Information Collection Policies in a Markov Decision Process Framework. Medical Decision Making 38:7, pages 797-809.
Crossref
Crossref
Dayton C. Marchese, Matthew E. Bates, Jeffrey M. Keisler, Maria L. Alcaraz, Igor Linkov & Elsa A. Olivetti. (2018) Value of information analysis for life cycle assessment: Uncertain emissions in the green manufacturing of electronic tablets. Journal of Cleaner Production 197, pages 1540-1545.
Crossref
Crossref
Haitham W. Tuffaha & Paul A. Scuffham. (2018) The Australian Managed Entry Scheme: Are We Getting it Right?. PharmacoEconomics 36:5, pages 555-565.
Crossref
Crossref
Hendrik Koffijberg, Saskia Knies & Mart P. Janssen. (2018) The Impact of Decision Makers’ Constraints on the Outcome of Value of Information Analysis. Value in Health 21:2, pages 203-209.
Crossref
Crossref
Vijay Singh GC, Marc Suhrcke, Wendy Hardeman, Stephen Sutton & Edward C.F. Wilson. (2018) Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care. Value in Health 21:1, pages 18-26.
Crossref
Crossref
John J. Dziak. 2018. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions
207
267
.
Eric Jutkowitz, Fernando Alarid-Escudero, Hyon K. Choi, Karen M. Kuntz & Hawre Jalal. (2017) Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis. PharmacoEconomics 35:10, pages 1073-1085.
Crossref
Crossref
Haitham W Tuffaha, Lazaros Andronis & Paul A Scuffham. (2017) Setting Medical Research Future Fund priorities: assessing the value of research. Medical Journal of Australia 206:2, pages 63-65.
Crossref
Crossref
M. P. Janssen. (2016) What does your data tell you? How transfusion chain data can support managerial decision‐making. ISBT Science Series 12:1, pages 38-45.
Crossref
Crossref
Noel Carroll, Marie Travers & Ita Richardson. 2017. Biomedical Engineering Systems and Technologies. Biomedical Engineering Systems and Technologies
319
339
.
Anna Heath, Ioanna Manolopoulou & Gianluca Baio. (2016) Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximation. Statistics in Medicine 35:23, pages 4264-4280.
Crossref
Crossref
Haitham W. TuffahaLouisa G. GordonPaul A. Scuffham. (2016) Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions. MDM Policy & Practice 1:1, pages 238146831664223.
Crossref
Crossref
Haitham W. Tuffaha, Mark Strong, Louisa G. Gordon & Paul A. Scuffham. (2016) Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective. Value in Health 19:4, pages 505-509.
Crossref
Crossref
Haitham W. Tuffaha, Brigid M. Gillespie, Wendy Chaboyer, Louisa G. Gordon & Paul A. Scuffham. (2015) Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds. Journal of Surgical Research 195:2, pages 612-622.
Crossref
Crossref
Henk Broekhuizen, Catharina G. M. Groothuis-Oudshoorn, Janine A. van Til, J. Marjan Hummel & Maarten J. IJzerman. (2015) A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. PharmacoEconomics 33:5, pages 445-455.
Crossref
Crossref
Haitham W. Tuffaha, Shelley Roberts, Wendy Chaboyer, Louisa G. Gordon & Paul A. Scuffham. (2015) Cost-Effectiveness and Value of Information Analysis of Nutritional Support for Preventing Pressure Ulcers in High-risk Patients: Implement Now, Research Later. Applied Health Economics and Health Policy 13:2, pages 167-179.
Crossref
Crossref
Véronique Raimond, Jean-Michel Josselin & Lise Rochaix. (2014) HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes. PharmacoEconomics 32:9, pages 825-839.
Crossref
Crossref
Zhengli Wang & Stefanos Zenios. (2020) Adaptive Design of Clinical Trials: A Sequential Learning Approach. SSRN Electronic Journal.
Crossref
Crossref